A recent study by researchers at McGill University’s Biomedical Ethics Unit found that one in five clinical trials is terminated for failing to recruit enough patients. In the study, the researchers reviewed more than 2500 trials that terminated early and determined that 19 per cent ended because the sponsor didn’t enroll enough patients to produce statistically valid results. Matthias Broschag at PAREXEL provides some significant input into how to avoid such setbacks.